Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.

Recently, fusion of ERG to the androgen-regulated, prostate-specific TMPRSS2 gene has been identified as the most frequent genetic alteration in prostate cancer. At low frequency, TMPRSS2-ETV1 and TMPRSS2-ETV4 fusion genes have been described. In this study,,we report two novel ETV4 fusion genes in prostate cancer: KLK2-ETV4 and CANT1-ETV4. Both gene fusions have important unique aspects. KLK2 is a well-established androgen-induced and prostate-specific gene. Fusion of KLK2 to ETV4 results in the generation of an additional ETV4 exon, denoted exon 4a. This novel exon delivers an ATG for the longest open reading frame, in this way avoiding translation start in KLK2 exon 1. Although wildtype CANT1 has two alternative first exons (exons I and 1a), only exon la was detected in CANT1-ETV4 fusion transcripts. We show that CANT1 transcripts starting at exon la have an androgen-induced and prostate-specific expression pattern, whereas CANT1 transcripts starting at exon I are not prostate specific. So, the two novel ETV4 fusion partners possess as predominant common characteristics androgen-induction and prostate-specific expression.